THE AMERICA ONE NEWS
Sep 25, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic

#politics

Fox News: White House tells federal agencies to prepare layoff plans as government shutdown looms
White House tells federal agencies to prepare layoff plans as government shutdown looms
OMB requires RIF plans before Oct. 1 shutdown; notices would go to staff on unfunded programs, plus furloughs.

Plans trimmed after FY2026 funding; only core staff kept. Memo blames Dems’ spending demands and backs a clean CR to avert a lapse.


Fox News: Dearborn mayor refuses to apologize for telling Christian minister he was 'not welcome here'
Dearborn mayor refuses to apologize for telling Christian minister he was 'not welcome here'
Dearborn Mayor Hammoud kept his "not welcome here" remark toward a Christian minister after a viral clash over an honorary street sign.

Barham urged unity and a Christian call to prayer, while residents pressed Hammoud to denounce Hamas and Hezbollah; the election looms.


#foreignaffairs

Times Of Israel: Tel Aviv flight makes emergency stop in Riyadh after Israeli traveler suffers stroke
Tel Aviv flight makes emergency stop in Riyadh after Israeli traveler suffers stroke
FlyDubai FZ1125, from Dubai to Tel Aviv, diverted to Riyadh after an Israeli passenger had a stroke; Saudi medics treated him.

Passengers waited on the tarmac for hours with little information; the episode underscores ongoing Saudi-Israel normalization.


#health

GB News: Huntington's disease: Scientists celebrate 'breathtaking' treatment that slows progression by 75%
Huntington's disease: Scientists celebrate 'breathtaking' treatment that slows progression by 75%
Researchers report a gene therapy slowing Huntington's by 75%, potentially adding decades. A 12–18 hr MRI surgery delivers engineered DNA to brain neurons. In 29 patients, progression slowed and some regained mobility; US approval for 2026; cost could limit access.